Today: 19 May 2026
Browse Category

NASDAQ:AFRM 24 September 2025 - 6 November 2025

Affirm Ramps Up Lending Firepower With $750M New York Life Deal and Worldpay Distribution as Q1 FY26 Results Arrive Today (Nov. 6)

Affirm Ramps Up Lending Firepower With $750M New York Life Deal and Worldpay Distribution as Q1 FY26 Results Arrive Today (Nov. 6)

Affirm announced a $750 million forward-flow deal with New York Life to fund installment loans through December 2026, enabling up to $1.75 billion in annual loan volume. The company also expanded distribution by integrating with Worldpay for Platforms, reaching over 1,000 SaaS platforms and $400 billion in processed payments. Affirm reports Q1 FY26 earnings after the bell.
6 November 2025
···
Affirm’s Rollercoaster: Profit Milestone, Insider Sell-Off & Big BNPL Bets – What’s Next for AFRM?

Affirm’s Rollercoaster: Profit Milestone, Insider Sell-Off & Big BNPL Bets – What’s Next for AFRM?

Affirm Holdings shares fell 8% to $82.73 on September 23 after CEO Max Levchin disclosed plans to sell about $58 million in stock, following $54 million in sales the prior month. The company posted a surprise Q4 profit, with EPS of $0.20 and revenue of $876 million, and announced new partnerships with Apple Pay, ServiceTitan, and Vagaro. Shares remain up over 50% year-to-date.
24 September 2025
··
1 2

Stock Market Today

  • Yacktman Asset Management Cuts Alphabet Inc. Stake Amid Mixed Institutional Moves
    May 19, 2026, 2:13 PM EDT. Yacktman Asset Management LP reduced its stake in Alphabet Inc. (NASDAQ:GOOG) by 3.1% in Q4, selling 36,606 shares and holding 1,129,807 shares valued at $354.5 million, representing 5% of its portfolio. Other institutional investors showed varied activity with Brighton Jones LLC and Worldquant Millennium Advisors LLC increasing their holdings significantly. Alphabet's stock saw multiple analyst ratings, including 'outperform' and 'buy' with target prices ranging from $345 to $450, reflecting positive sentiment from firms like Scotiabank, TD Cowen, and Deutsche Bank. Institutional investors own 27.26% of Alphabet's shares. The stock remains a top focus amid ongoing trading by hedge funds and asset managers.

Latest articles

Why Recursion Stock Just Hit a 52-Week Low — and the FDA Update Traders Are Waiting For

Why Recursion Stock Just Hit a 52-Week Low — and the FDA Update Traders Are Waiting For

19 May 2026
New York, May 19, 2026, 2:04 PM EDT Recursion Pharmaceuticals shares fell in Tuesday afternoon trading after touching a fresh 52-week low, keeping pressure on one of the better-known AI drug-discovery names even as the company points to clinical progress and a cash runway into 2028. The stock was recently down about 2.2% at $2.825, after trading as low as $2.77, with volume above 10 million shares and a market value near $1.49 billion. Investing.com reported earlier Tuesday that Recursion had hit a 52-week low at $2.79 and said the shares were down about 36% over the past year. (Investing.com)
Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

19 May 2026
U.S. stocks fell Tuesday as the 10-year Treasury yield reached its highest point since January 2025, pressuring growth shares. Nvidia drew the most attention ahead of its earnings, with options markets pricing in a possible $355 billion swing in value. Dell highlighted new AI infrastructure partnerships, while ServiceNow received a fresh Buy rating from Bank of America.
Nvidia’s Earnings Could Make or Break the AI Stock Trade

Nvidia’s Earnings Could Make or Break the AI Stock Trade

19 May 2026
Nvidia rose 0.8% ahead of its earnings report, while CoreWeave dropped 3.7% after Google and Blackstone announced a $5 billion U.S. AI cloud venture using Google’s custom TPUs. The new venture will offer 500 megawatts of data-center capacity by 2027. AMD and Micron also gained, but Microsoft and Broadcom slipped. Investors are watching whether Nvidia can maintain dominance as competition in AI inference intensifies.
Go toTop